Want to see HK:1110 full AI Analyst Report?
Total Valuation
Kingworld Medicines Group Ltd. has a market cap or net worth of HK$233.50M. The enterprise value is HK$569.12M.
Market CapHK$233.50M
Enterprise ValueHK$569.12M
Share Statistics
Kingworld Medicines Group Ltd. has 622,499,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding622,499,940
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kingworld Medicines Group Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 3.72%.
Return on Equity (ROE)0.02
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)3.72%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee1.29M
Profits Per Employee80.78K
Employee Count711
Asset Turnover0.64
Inventory Turnover5.02
Valuation Ratios
The current PE Ratio of Kingworld Medicines Group Ltd. is 17.3. Kingworld Medicines Group Ltd.’s PEG ratio is -0.33.
PE Ratio17.3
PS Ratio0.30
PB Ratio0.44
Price to FCF4.99
Price to Operating Cash Flow4.99
PEG Ratio-0.33
Income Statement
In the last 12 months, Kingworld Medicines Group Ltd. had revenue of 917.34M and earned 11.28M in profits. Earnings per share was 0.02.
Revenue917.34M
Gross Profit247.91M
Operating Income63.16M
Pretax Income57.43M
Net Income11.28M
EBITDA82.70M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was 38.39M and capital expenditures -39.57M, giving a free cash flow of -1.18M billion.
Operating Cash Flow38.39M
Free Cash Flow-1.18M
Free Cash Flow per Share>-0.01
Dividends & Yields
Kingworld Medicines Group Ltd. pays an annual dividend of HK$0.032, resulting in a dividend yield of 8.23%
Dividend Per ShareHK$0.032
Dividend Yield8.23%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.29
52-Week Price Change-23.00%
50-Day Moving Average0.42
200-Day Moving Average0.46
Relative Strength Index (RSI)43.21
Average Volume (3m)2.42M
Important Dates
Kingworld Medicines Group Ltd. upcoming earnings date is Mar 30, 2027, TBA (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateMar 30, 2027
Ex-Dividend Date―
Financial Position
Kingworld Medicines Group Ltd. as a current ratio of 1.09, with Debt / Equity ratio of 73.44%
Current Ratio1.09
Quick Ratio0.85
Debt to Market Cap1.51
Net Debt to EBITDA2.05
Interest Coverage Ratio4.50
Taxes
In the past 12 months, Kingworld Medicines Group Ltd. has paid 18.54M in taxes.
Income Tax18.54M
Effective Tax Rate0.32
Enterprise Valuation
Kingworld Medicines Group Ltd. EV to EBITDA ratio is 5.36, with an EV/FCF ratio of 8.07.
EV to Sales0.48
EV to EBITDA5.36
EV to Free Cash Flow8.07
EV to Operating Cash Flow5.24
Balance Sheet
Kingworld Medicines Group Ltd. has HK$188.35M in cash and marketable securities with HK$438.04M in debt, giving a net cash position of -HK$249.70M billion.
Cash & Marketable SecuritiesHK$188.35M
Total DebtHK$438.04M
Net Cash-HK$249.70M
Net Cash Per Share-HK$0.40
Tangible Book Value Per ShareHK$1.02
Margins
Gross margin is 30.47%, with operating margin of 6.89%, and net profit margin of 1.23%.
Gross Margin30.47%
Operating Margin6.89%
Pretax Margin6.26%
Net Profit Margin1.23%
EBITDA Margin9.02%
EBIT Margin6.18%
Analyst Forecast
The average price target for Kingworld Medicines Group Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-13.82%
EPS Growth Forecast112.24%